Literature DB >> 7164167

Trypanosoma brucei rhodesiense infection in vervet monkeys. II. Provocation of the encephalitic late phase by treatment of infected monkeys.

H Schmidt, P Sayer.   

Abstract

Four out of 8 monkeys infected with Trypanosoma rhodesiense and treated with trypanocidal drugs at various intervals after infection (days 55-58, days 62-65, day 68) developed encephalitis. In 2 of these animals, killed 2 weeks after treatment, the encephalitis presenting was incipient; the other 2 monkeys died as a result of severe encephalitis a little more than 2 and 3 months after treatment, respectively. At the time of treatment, the animals revealed a parasitization of the CSF, but there were no clinical or neurological signs of any involvement of the central nervous system. The observations confirm observations made in human trypanosomiasis, and in experiments on rodents, which indicate that the encephalitic late phase may result from inadequate treatment. These observations may indicate that the encephalitis of the late phase may be methodologically provoked by infection and subliminal treatment after parasitization of the CSF, and that this procedure may be more promising of success than the method of infection only, as a method for the production of an animal model of the encephalitic late phase.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7164167

Source DB:  PubMed          Journal:  Tropenmed Parasitol        ISSN: 0303-4208


  10 in total

1.  African trypanosomiasis: haematogenic brain parasitism early in experimental infection through bypassing the blood-brain barrier, with considerations on brain trypanosomiasis in man.

Authors:  H Schmidt; J M Bafort
Journal:  Parasitol Res       Date:  1987       Impact factor: 2.289

2.  Efficacy of the novel diamidine compound 2,5-Bis(4-amidinophenyl)- furan-bis-O-Methlylamidoxime (Pafuramidine, DB289) against Trypanosoma brucei rhodesiense infection in vervet monkeys after oral administration.

Authors:  R E Mdachi; J K Thuita; J M Kagira; J M Ngotho; G A Murilla; J M Ndung'u; R R Tidwell; J E Hall; R Brun
Journal:  Antimicrob Agents Chemother       Date:  2008-12-08       Impact factor: 5.191

3.  The pathogenesis of trypanosomiasis of the CNS. Studies on parasitological and neurohistological findings in trypanosoma rhodesiense infected vervet monkeys.

Authors:  H Schmidt
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

Review 4.  Vaccination against trypanosomiasis: can it be done or is the trypanosome truly the ultimate immune destroyer and escape artist?

Authors:  Florencia La Greca; Stefan Magez
Journal:  Hum Vaccin       Date:  2011-11

5.  Chemotherapy of second stage human African trypanosomiasis: comparison between the parenteral diamidine DB829 and its oral prodrug DB868 in vervet monkeys.

Authors:  John K Thuita; Kristina K Wolf; Grace A Murilla; Arlene S Bridges; David W Boykin; James N Mutuku; Qiang Liu; Susan K Jones; Charles O Gem; Shelley Ching; Richard R Tidwell; Michael Z Wang; Mary F Paine; Reto Brun
Journal:  PLoS Negl Trop Dis       Date:  2015-02-05

6.  Delineating neuroinflammation, parasite CNS invasion, and blood-brain barrier dysfunction in an experimental murine model of human African trypanosomiasis.

Authors:  Jean Rodgers; Barbara Bradley; Peter G E Kennedy
Journal:  Methods       Date:  2017-06-19       Impact factor: 3.608

7.  Pharmacology of DB844, an orally active aza analogue of pafuramidine, in a monkey model of second stage human African trypanosomiasis.

Authors:  John K Thuita; Michael Z Wang; John M Kagira; Cathrine L Denton; Mary F Paine; Raymond E Mdachi; Grace A Murilla; Shelley Ching; David W Boykin; Richard R Tidwell; James E Hall; Reto Brun
Journal:  PLoS Negl Trop Dis       Date:  2012-07-24

8.  Trypanosoma brucei rhodesiense transmitted by a single tsetse fly bite in vervet monkeys as a model of human African trypanosomiasis.

Authors:  John K Thuita; John M Kagira; David Mwangangi; Enock Matovu; C M R Turner; Daniel Masiga
Journal:  PLoS Negl Trop Dis       Date:  2008-05-14

9.  IL-6 is upregulated in late-stage disease in monkeys experimentally infected with Trypanosoma brucei rhodesiense.

Authors:  Dawn Nyawira Maranga; John Maina Kagira; Christopher Kariuki Kinyanjui; Simon Muturi Karanja; Naomi Wangari Maina; Maina Ngotho
Journal:  Clin Dev Immunol       Date:  2013-09-30

10.  Mouse experiments demonstrate differential pathogenicity and virulence of Trypanosoma brucei rhodesiense strains.

Authors:  Limo William Kipkorir; Thuita Kibuthu John; Orindi Benedict Owino; Oidho John; Shivairo Robert; Masiga Daniel; Adung'a Vincent Owino
Journal:  Exp Parasitol       Date:  2021-07-17       Impact factor: 2.132

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.